Clinical Trial Update: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a dendritic cell/tumor fusion vaccine with GM-CSF and Imiquimod for ovarian cancer, primary peritoneal cancer, and fallopian t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Dendritic cell/tumor fusion vaccine
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Imiquimod (imiquimod)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING